Cargando…
Use of Nonhuman Primate Models to Develop Mucosal AIDS Vaccines
The HIV vaccines tested in the halted Step efficacy trial and the modestly successful phase 3 RV144 trial were designed to elicit strong systemic immune responses; therefore, strategies to direct immune responses into mucosal sites should be tested in an effort to improve AIDS vaccine efficacy. Howe...
Autores principales: | Genescà, Meritxell, Miller, Christopher J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824120/ https://www.ncbi.nlm.nih.gov/pubmed/20425054 http://dx.doi.org/10.1007/s11904-009-0035-7 |
Ejemplares similares
-
The Use of Nonhuman Primate Models in HIV Vaccine Development
por: Morgan, Cecilia, et al.
Publicado: (2008) -
Using the Nonhuman Primate Model of HCMV to Guide Vaccine Development
por: Deere, Jesse D., et al.
Publicado: (2014) -
Using the Pathogenic and Nonpathogenic Nonhuman Primate Model for Studying Non-AIDS Comorbidities
por: Pandrea, Ivona, et al.
Publicado: (2015) -
Nonhuman Primate Models of Immunosenescence
por: Rivera, Andrea, et al.
Publicado: (2019) -
Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS
por: Deere, Jesse D., et al.
Publicado: (2016)